Cost-utility of computed tomography in patients with atypical chest pain clinically referred for invasive coronary angiography: randomised controlled trial
European Radiology · 2025
DOI: 10.1007/s00330-025-11692-0 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift European Radiology, 2025. Verfasst von Maria Bosserdt und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. Hauptthemen laut MEDLINE: Coronary Angiography, Chest Pain, Tomography, X-Ray Computed, Computed Tomography Angiography. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Background
Computed tomography (CT) is as safe as invasive coronary angiography (ICA) in the incidence of major adverse cardiovascular events in patients with atypical chest pain. However, the cost-utility of CT and ICA in healthcare after long-term follow-up is still unknown.
Methods
A prespecified cost-utility analysis (CUA) of 329 patients with atypical chest pain from a single-centre randomised trial compared CT and ICA. The CUA was conducted from the health sector perspective up to a 3-year follow-up using quality-adjusted life years (QALYs) from the EQ-5D-3L questionnaire. Costs were obtained from each individual’s outpatient and inpatient billing data and included cardiovascular medications, hospitalisations, emergency visits, cardiologist visits, and cardiac examinations. The analysis implemented 500 multiple imputations and 1000 bootstrapping iterations per imputed dataset, followed by calculating the net monetary benefit (NMB).
Results
There was no significant difference in mean QALYs at either 1-year (CT: 0.69 (95% CI: 0.66–0.72); ICA: 0.71 (95% CI: 0.68–0.74); difference: −0.02 (−0.06 to 0.03)) or 3-year follow-up (CT: 2.09 (95% CI: 2.00–2.17); ICA: 2.11 (95% CI: 2.02–2.19); difference: −0.02 (95% CI: −0.14 to 0.12)), while the mean cost per patient was significantly lower in the CT compared with the ICA at both 1-year (difference (€): −1647.8, 95% CI: −2198.3 to 1093.3) and at 3-year follow-ups (difference (€): −1543.3, 95% CI: −2228.0 to −830.0). At a willingness-to-pay of €20,000/QALY, the mean incremental NMB of CT over ICA was €1256.5 (164.8–2331.8) at 1-year and €1202.0 (95% CI: −1378.7 to −3961) at 3-year follow-ups.
Conclusion
A CT-first strategy for the management of patients with atypical angina or chest pain was more cost-effective than a direct ICA strategy.
Trial registration
ClinicalTrials.gov NCT00844220. Key Points Question What is the cost-effectiveness of using CT compared to invasive coronary angiography (ICA) for diagnosing coronary artery disease in patients with atypical chest pain?
Findings
A CT-first diagnostic strategy was €1543 less costly per patient over a 3-year follow-up, yielding similar quality-adjusted life years compared to ICA. Clinical relevance CT offers a cost-effective, non-invasive alternative to ICA for patients with atypical chest pain, reducing healthcare costs significantly without compromising patient-reported outcomes or quality of life. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Department of Radiology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. mahmoud.mohamed@charite.de.
- Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Institute of Public Health, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Deutsches Herzzentrum der Charité (DHZC), Berlin, Germany.
- Department of Health Policy, Corvinus University of Budapest, Budapest, Hungary.
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Bosserdt, M., Mohamed, M., Neumann, K., Rieckmann, N., Dreger, H., Brodszky, V., Höfer, S., Reinhold, T., Mielke, A. M., & Dewey, M. (2025). Cost-utility of computed tomography in patients with atypical chest pain clinically referred for invasive coronary angiography: randomised controlled trial. European Radiology. https://doi.org/10.1007/s00330-025-11692-0
Vancouver
Bosserdt M, Mohamed M, Neumann K, Rieckmann N, Dreger H, Brodszky V, et al. Cost-utility of computed tomography in patients with atypical chest pain clinically referred for invasive coronary angiography: randomised controlled trial. European Radiology. 2025. doi:10.1007/s00330-025-11692-0
BibTeX
@article{Bosserdt2025,
author = {Bosserdt, Maria and Mohamed, Mahmoud and Neumann, Konrad and Rieckmann, Nina and Dreger, Henryk and Brodszky, Valentin and Höfer, Stefan and Reinhold, Thomas and Mielke, Anna-Maria and Dewey, Marc},
title = {Cost-utility of computed tomography in patients with atypical chest pain clinically referred for invasive coronary angiography: randomised controlled trial},
journal = {European Radiology},
year = {2025},
doi = {10.1007/s00330-025-11692-0}
}
EUVIMED